The Diabetes Center Mergentheim is a large and modern treatment center for people with diabetes mellitus in Germany. The center includes the Diabetes-Clinic, the Diabetes-Academy, FIDAM, the Diabetes-Medical Practice, ConDiaZ and InsulinJA.

There are 155 (2011) beds in Diabetes Center Mergentheim.

During the past decade, Diabetes Center Mergentheim conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diabetes Center Mergentheim" #1 sponsor was "Forschungsinstitut der Diabetes Akademie Mergentheim" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Abbott Diabetes Care" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Norbert Hermanns" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes Center Mergentheim" #1 collaborator was "German Center for Diabetes Research" with 2 trials as a collaborator, "Helmholtz Zentrum München" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "German Diabetes Center" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes Center Mergentheim" are "Diabetes Mellitus, Type 1" (3 trials), "Depressive Symptoms" (2 trials), "Diabetic Foot Ulcers" (2 trials), "Type 2 Diabetes" (2 trials) and "Affective Disorders" (1 trials). Many other conditions were trialed in "Diabetes Center Mergentheim" in a lesser frequency.

Most popular intervention types in "Diabetes Center Mergentheim" are "Device" (4 trials), "Behavioral" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Accu-Chek® Solo micropump system" (1 trials), "Activation of personal and social resources" (1 trials), "Cognitive restructuring of diabetes-related problems" (1 trials), "Current CT program" (1 trials) and "Current ICT program (ACC-ICT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes Center Mergentheim" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes Center Mergentheim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Diabetes Center Mergentheim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes Center Mergentheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".